ATE232298T1 - Bioluminenztest für agonisten oder antagonisten eines kalzium-gekuppelten-rezeptors - Google Patents

Bioluminenztest für agonisten oder antagonisten eines kalzium-gekuppelten-rezeptors

Info

Publication number
ATE232298T1
ATE232298T1 AT99930956T AT99930956T ATE232298T1 AT E232298 T1 ATE232298 T1 AT E232298T1 AT 99930956 T AT99930956 T AT 99930956T AT 99930956 T AT99930956 T AT 99930956T AT E232298 T1 ATE232298 T1 AT E232298T1
Authority
AT
Austria
Prior art keywords
calcium
coupled receptor
bioluminence
agonists
antagonists
Prior art date
Application number
AT99930956T
Other languages
English (en)
Inventor
Vincent Dupriez
Michel Detheux
Marc Parmentier
Original Assignee
Euroscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237065&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE232298(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euroscreen Sa filed Critical Euroscreen Sa
Application granted granted Critical
Publication of ATE232298T1 publication Critical patent/ATE232298T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT99930956T 1998-07-06 1999-07-06 Bioluminenztest für agonisten oder antagonisten eines kalzium-gekuppelten-rezeptors ATE232298T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98870149 1998-07-06
PCT/BE1999/000087 WO2000002045A2 (en) 1998-07-06 1999-07-06 Bioluminescent assay for agonists or antagonists of a calcium-coupled receptor

Publications (1)

Publication Number Publication Date
ATE232298T1 true ATE232298T1 (de) 2003-02-15

Family

ID=8237065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930956T ATE232298T1 (de) 1998-07-06 1999-07-06 Bioluminenztest für agonisten oder antagonisten eines kalzium-gekuppelten-rezeptors

Country Status (9)

Country Link
US (1) US6872538B1 (de)
EP (1) EP1145002B2 (de)
JP (1) JP3495987B2 (de)
AT (1) ATE232298T1 (de)
CA (1) CA2336929C (de)
DE (1) DE69905291T3 (de)
DK (1) DK1145002T4 (de)
ES (1) ES2192060T5 (de)
WO (1) WO2000002045A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US6248542B1 (en) 1997-12-09 2001-06-19 Massachusetts Institute Of Technology Optoelectronic sensor
DE10008373C2 (de) * 2000-02-23 2002-11-28 Helmut Adelsberger Verfahren und Vorrichtung zur Bestimmung der Ionenkanalaktivität
EP1750129B1 (de) 2001-02-07 2011-04-20 Massachusetts Institute of Technology Optoelektronisches Detektionssystem
US8216797B2 (en) * 2001-02-07 2012-07-10 Massachusetts Institute Of Technology Pathogen detection biosensor
US7422860B2 (en) 2001-02-07 2008-09-09 Massachusetts Institute Of Technology Optoelectronic detection system
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
AU2002256694A1 (en) * 2001-03-20 2002-10-03 Euroscreen S.A. Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor
GB0108143D0 (en) * 2001-03-31 2001-05-23 Univ Dundee High-throughput screen
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
WO2003057730A1 (en) 2002-01-07 2003-07-17 Euroscreen S.A. Ligand for g-protein coupled receptor gpr43 and uses thereof
WO2004041862A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
GB0228139D0 (en) * 2002-12-03 2003-01-08 Kozlova Zwinderman Olga Fungal biosensor for contaminant detection
RU2357974C2 (ru) 2003-01-10 2009-06-10 Аблинкс Н.В. Терапевтические полипептиды, их гомологи, их фрагменты и их применение для модуляции агрегации, опосредованной тромбоцитами
ATE485307T1 (de) 2003-11-07 2010-11-15 Ablynx Nv Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
CA2559809A1 (en) 2004-03-12 2005-11-10 Human Genome Sciences, Inc. Antibodies against human g-protein chemokine receptor (ccr5) hdgnr10
ITMI20040598A1 (it) * 2004-03-26 2004-06-26 Carlotta Giorgi Metodo per la rilevazione di parametri intracellulari con sonde proteiche luminescenti per lo screening di molecole in grado di alterare detti parametri
CA2504920C (en) 2004-05-14 2014-04-01 Euroscreen S.A. Ligand for g-protein coupled receptor fprl2 and uses thereof
RU2464276C2 (ru) 2005-05-18 2012-10-20 Аблинкс Н.В. Улучшенные нанотела против фактора некроза опухоли-альфа
DK2444424T3 (en) 2005-05-20 2018-12-03 Ablynx Nv IMPROVED NANOL BODIES (TM) FOR TREATING AGGREGATED MEDICINAL DISORDERS
WO2007100618A2 (en) * 2006-02-23 2007-09-07 Atto Bioscience Novel cell-based phosphodiesterase assays
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
WO2011008250A1 (en) 2009-07-14 2011-01-20 Millipore Corporation Modified photoproteins with increased affinity for calcium and enhanced bioluminescence and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422266A (en) 1984-12-31 1995-06-06 University Of Georgia Research Foundation, Inc. Recombinant DNA vectors capable of expressing apoaequorin
JPH01285196A (ja) 1988-05-11 1989-11-16 Chisso Corp 発光蛋白エクオリンの製造法
DE68922971T2 (de) 1988-12-06 1995-10-19 Chisso Corp Mit einem Protein mit spezifischer Bindungsaktivität fusioniertes Aequorin, seine Herstellung, Reinigung und Nachweismethode.
JPH02253162A (ja) 1989-03-27 1990-10-11 Chisso Corp 特異的結合能を有する物質と結合したエクオリンを用いる検出法
JPH03153700A (ja) 1989-11-09 1991-07-01 Chisso Corp 物理吸着法により担体に固定化されたエクオリン活性を示す蛋白質
US5714666A (en) 1993-02-09 1998-02-03 Children's Hospital Of Philadelphia Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells
US5744320A (en) 1995-06-07 1998-04-28 Promega Corporation Quenching reagents and assays for enzyme-mediated luminescence

Also Published As

Publication number Publication date
DE69905291T2 (de) 2003-11-06
EP1145002B2 (de) 2008-12-10
EP1145002B1 (de) 2003-02-05
WO2000002045A2 (en) 2000-01-13
DE69905291T3 (de) 2009-06-25
CA2336929A1 (en) 2000-01-13
DK1145002T3 (da) 2003-05-05
ES2192060T3 (es) 2003-09-16
EP1145002A2 (de) 2001-10-17
WO2000002045A3 (en) 2001-11-08
ES2192060T5 (es) 2009-05-01
DK1145002T4 (da) 2009-03-16
JP2002519699A (ja) 2002-07-02
DE69905291D1 (de) 2003-03-13
US6872538B1 (en) 2005-03-29
CA2336929C (en) 2005-10-04
JP3495987B2 (ja) 2004-02-09

Similar Documents

Publication Publication Date Title
ATE232298T1 (de) Bioluminenztest für agonisten oder antagonisten eines kalzium-gekuppelten-rezeptors
Triggianese et al. Prolactin and natural killer cells: evaluating the neuroendocrine‐immune axis in women with primary infertility and recurrent spontaneous abortion
ES2129658T3 (es) Identificacion de ligandos mediante amplificacion selectiva de celulas transfectadas con receptores.
ATE226247T1 (de) Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
PT1171873E (pt) Aparelho e metodo para detectar emocoes na voz humana
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
BR0312587A (pt) equipamento e método para transferência sem fio de mensagens transparente e integrada em ambiente multimodal
DE69029812D1 (de) Elemente für retinsäureantwortzusammensetzung und nachweisverfahren
CA2057854A1 (en) Pdgf .alpha.-receptor
BR9915055A (pt) Teste diagnóstico de tuberculose
AU8749498A (en) Methods for identifying or screening agonists for and antagonists to ppar
NO990823L (no) Homocysteindesulfurase fra protozoen Trichomonas Vaginalis
AR010041A1 (es) Agonistas multifuncionales quimericos de receptores de hematopoyetina
NZ524693A (en) Methods for identifying VPAC receptor agonists for treating muscle atrophy using vasoactive intestinal peptide receptors
CA2091637A1 (en) Call Progress Monitoring
DK1185873T3 (da) Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitet
GB2433319A (en) In vitro test for studying compound predicting pharmacologic and/or pharmacokinetic and/or pharmacodynamic parameters of a compound
Chung et al. Dopamine as a neuroactive substance in the jellyfish Polyorchis penicillatus
DK1095275T3 (da) Endogen, konstitutivt aktiverede G-protein-koblede orphan-receptorer
ES2104945T3 (es) Un metodo in vitro para evaluar los efectos de una sustancia.
WO2002075273A3 (en) Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor
ATE138976T1 (de) Nachweisverfahren für den totalgehalt an gonadotropen alpha-peptidketten
HU9602558D0 (en) Means for treating auto-immune diseases and method of treatment
DE69625912D1 (de) Screening-test für kalium-kanal agonisten
MY130846A (en) Method for providing liquid and solid components of a sample for use in assay methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1145002

Country of ref document: EP

EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1145002

Country of ref document: EP